Jason Butler
Stock Analyst at Citizens JMP
(4.83)
# 454
Out of 5,058 analysts
711
Total ratings
49.7%
Success rate
18.4%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RZLT Rezolute | Reiterated: Buy | $11 → $15 | $4.23 | +254.61% | 34 | Oct 6, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $36 → $33 | $19.25 | +71.43% | 50 | Sep 25, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $932 → $1,200 | $818.30 | +46.65% | 44 | Aug 18, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $18 → $17 | $5.39 | +215.40% | 36 | Aug 17, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $96 → $110 | $63.43 | +73.42% | 63 | Aug 7, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $92 → $93 | $116.82 | -20.39% | 49 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $25 → $28 | $10.23 | +173.70% | 11 | Aug 6, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $131 → $187 | $87.98 | +112.55% | 14 | Jun 2, 2026 | |
| GHRS GH Research | Reiterated: Buy | $42 → $39 | $18.56 | +110.13% | 24 | May 15, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $62 → $55 | $11.84 | +364.53% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $7.36 | +49.56% | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $20 | $8.37 | +138.95% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $2.35 | +495.74% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $18 | $3.18 | +466.04% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $3.60 | +177.78% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $7.00 | +171.43% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 → $80 | $28.33 | +182.39% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $12 | $4.61 | n/a | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $7.39 | n/a | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $38 | $18.38 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.066 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1714 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.10 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.19 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $70 | $73.53 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.09 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.48 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $4.22 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.50 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $254.45 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.02 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $40.25 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.88 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.72 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.07 | n/a | 1 | Mar 26, 2013 |
Rezolute
Oct 6, 2026
Reiterated: Buy
Price Target: $11 → $15
Current: $4.23
Upside: +254.61%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $36 → $33
Current: $19.25
Upside: +71.43%
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $932 → $1,200
Current: $818.30
Upside: +46.65%
LeonaBio
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $5.39
Upside: +215.40%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $63.43
Upside: +73.42%
Halozyme Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $92 → $93
Current: $116.82
Upside: -20.39%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $10.23
Upside: +173.70%
ABIVAX Société Anonyme
Jun 2, 2026
Reiterated: Buy
Price Target: $131 → $187
Current: $87.98
Upside: +112.55%
GH Research
May 15, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $18.56
Upside: +110.13%
Avalo Therapeutics
May 14, 2026
Reiterated: Buy
Price Target: $62 → $55
Current: $11.84
Upside: +364.53%
May 14, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $7.36
Upside: +49.56%
May 8, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $8.37
Upside: +138.95%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $2.35
Upside: +495.74%
Mar 26, 2026
Reiterated: Buy
Price Target: $19 → $18
Current: $3.18
Upside: +466.04%
Feb 26, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $3.60
Upside: +177.78%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $7.00
Upside: +171.43%
Nov 7, 2025
Reiterated: Buy
Price Target: $77 → $80
Current: $28.33
Upside: +182.39%
Oct 9, 2025
Reiterated: Buy
Price Target: $9 → $12
Current: $4.61
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $7.39
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $42 → $38
Current: $18.38
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.066
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.1714
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $4.10
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.19
Upside: n/a
Jan 9, 2020
Reiterated: Buy
Price Target: $58 → $70
Current: $73.53
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.48
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $4.22
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.50
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $254.45
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.02
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $40.25
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $11.88
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $14.72
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $2.07
Upside: n/a